New ‘designer drugs’ pose growing threat to road safety in the US
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Aug-2025 07:11 ET (15-Aug-2025 11:11 GMT/UTC)
Researchers from the US have reported the initial results from the first quantitative study to focus on the contribution of multiple new psychoactive substances (NPS) from a range of classes to roadway crashes in the US. They found that 2% of 1,000 adults who visited one of two trauma centers in California within six hours after being involved in a roadway crash had traces of NPS in their blood. The most frequent were bromazolam, para-fluorofentanyl, and mitragynine. In most (88%) of these positive cases, NPS had been taken together with traditional recreational drugs such as fentanyl, methamphetamine, and cocaine. These results indicate that NPS are a new concern in roadway crashes and put lives at risk.
Researchers have uncovered a hormone-sensitive neural circuit between the hypothalamic medial preoptic area and paraventricular nucleus that, when modulated, powerfully alters depressive-like behaviors in a mouse model of postpartum depression, pointing to a promising target for future treatments.
Laboratory medicine is an essential part of the diagnostic process, supporting clinical decisions, guiding and addressing therapy. The recent COVID-19 pandemic illustrated well the key role of laboratory medicine in the diagnosis, management and prognosis of SARS-CoV-2 infected patients. Technological advances improved the laboratory diagnosis and patients’ management and others appear very promising as clustered regularly interspaced short palindromic repeats (CRISPR) or artificial intelligence (AI). This review describes the current diagnostic assays routinely used in laboratory as well as the novel technologies not in routine yet but that represent future directions and will probably dominate the laboratory in the next years. Serology is important for detecting antibodies and/or antigens of the infectious pathogens or for epidemiological purposes, while real-time PCR with its high sensitivity and specificity has a key role in pathogen detection in different biological matrices and in monitoring the therapy. Nanochip-based technologies make possible delivering a laboratory report at the patient’s bed or in settings where a laboratory-based hospital is not available. Next generation sequencing (NGS) is a massively high throughput parallel sequencing technology that allows the simultaneous sequence of billions of DNA fragments in a short time frame. This technology can be used to detect drug-associated mutations, minority species within an infected patient or for pathogen identification. CRISPR-based technology is a fast and accurate diagnostic method that can be applied to different human diseases including infectious diseases. Artificial intelligence is increasingly used in laboratory medicine. In clinical microbiology, it is used to build up diagnosis analyzing genomic information or mass spectra from isolated bacteria, for predicting antibiotic sensitivity or for processing in a short time a large number of images with meaningful results. Thus, the laboratory is becoming increasingly automated and interwoven with sophisticated software or algorithms that will increase the sensitivity and specificity of diagnoses, besides reducing time to results.
The world has made unprecedented progress in vaccinating children against life-threatening disease since WHO established the Expanded Programme on Immunization (EPI) in 1974. Despite the progress of the past 50 years, the last two decades have also been marked by stagnating childhood vaccination rates and wide variation in vaccine coverage. These challenges have been further exacerbated by the COVID-19 pandemic, leaving millions of children vulnerable to preventable diseases and death, according to a major new analysis from the Global Burden of Disease Study Vaccine Coverage Collaborators, published in The Lancet.